Core Viewpoint - The stock price of Fengbei Bio has dropped nearly 30% from its debut high of 76 yuan to 54.42 yuan, highlighting the "listing peak" phenomenon in the A-share market [1] Group 1: Stock Performance - Fengbei Bio experienced a turnover rate of 135% and a trading volume of 2.7 billion yuan in the first two trading days, indicating concentrated selling by institutional investors and passive buying by retail investors [3] - Investors who bought shares on the first day faced a gap down of 10% the next day, followed by a further decline of 4.75%, with some high-flying investors suffering losses of up to 28.5% [3] - Despite the continuous decline in stock price, Fengbei Bio maintains a price-to-earnings ratio of around 50, significantly higher than the industry average [5] Group 2: Business Model and Market Dependency - Fengbei Bio's main business involves converting waste oil into biodiesel, but its profitability is heavily reliant on the EU market [3] - The EU's imposition of a 23.7% anti-dumping tax on Chinese biodiesel in 2024 is expected to lead to a drastic drop in the company's revenue from the EU, projected to be less than 50 million yuan, only 15% of the revenue from the same period in 2023 [3] Group 3: Financial Health and R&D Investment - The company's R&D expense ratio for 2023 is only 3.39%, significantly lower than the industry average, indicating a lack of technological premium capability [6] - Fengbei Bio's gross margin of 13.95% is less than half of the industry average, reflecting challenges in maintaining competitive advantage [6] Group 4: Market Behavior and Investor Sentiment - Historical data shows a negative correlation between new stock first-month gains and issuance price-to-earnings ratios; when the ratio exceeds 40, the average first-day gain drops from 75.79% to 16.93% [5] - The phenomenon of "blindly chasing new stocks" has led to a high percentage of retail investors (94.7%) suffering losses after buying on the first day [5] - The market sentiment is closely linked to the new stock's breaking rate, with about 30% of new stocks experiencing a first-day drop in 2025, indicating that the strategy of blindly investing in new stocks is becoming ineffective [7]